327 related articles for article (PubMed ID: 12506469)
21. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Shinoda M; Hatooka S; Mori S; Mitsudomi T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
[TBL] [Abstract][Full Text] [Related]
22. [Phase III clinical trial for esophageal cancer using radiotherapy].
Ogino T
Gan To Kagaku Ryoho; 1995 Feb; 22(3):341-9. PubMed ID: 7533489
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy of esophageal carcinoma].
Iizuka T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):597-601. PubMed ID: 3355181
[TBL] [Abstract][Full Text] [Related]
24. [Progress in adjuvant therapy for colorectal cancer].
Kohnoe S; Kakeji Y; Maehara Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
[TBL] [Abstract][Full Text] [Related]
25. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
Ohtsu A
Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
[TBL] [Abstract][Full Text] [Related]
26. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
29. [Chemoradiotherapy for esophageal cancer].
Fujita H; Sueyoshi S; Tanaka T; Sasahara H; Matono S; Yamana H; Shirouzu K; Suzuki G; Hayabuchi N
Gan To Kagaku Ryoho; 2003 Jul; 30(7):937-43. PubMed ID: 12894707
[TBL] [Abstract][Full Text] [Related]
30. [A case of advanced esophageal cancer made resectable by preoperative combination therapy with 5-FU and CDDP].
Shimakawa T; Naritaka Y; Wagatsuma Y; Katsube T; Ishikawa S; Watanabe T; Miura K; Wakasugi S; Konno S; Yagawa H
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1977-81. PubMed ID: 7487130
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of cases of complete response (CR) in esophageal and gastric cancer].
Suzuki T; Okazumi S; Ochiai T
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2059-65. PubMed ID: 11103237
[TBL] [Abstract][Full Text] [Related]
32. Radiation and chemoradiation therapy for esophageal adenocarcinoma.
Bosset JF; Lorchel F; Mantion G; Buffet J; Créhange G; Bosset M; Chaigneau L; Servagi S
J Surg Oncol; 2005 Dec; 92(3):239-45. PubMed ID: 16299784
[TBL] [Abstract][Full Text] [Related]
33. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
34. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
35. [Multidisciplinary treatment of cancer of the esophagus].
Hoshino A; Nishihira T; Hirayama K; Shineha R; Mori S
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1141-6. PubMed ID: 8333741
[TBL] [Abstract][Full Text] [Related]
36. [Cisplatin, 5-fluorouracil and leucovorin combination chemotherapy-added radiation therapy for advanced esophageal cancer--a case report].
Hokita S; Fukura K; Imamura H; Kimura S; Toyoyama H; Hamahata H; Nakai H; Imakiire K; Okubo K; Miyaji K
Gan To Kagaku Ryoho; 1995 Feb; 22(3):399-402. PubMed ID: 7880112
[TBL] [Abstract][Full Text] [Related]
37. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.
Tachibana M; Yoshimura H; Kinugasa S; Shibakita M; Dhar DK; Ueda S; Fujii T; Nagasue N
Eur J Surg Oncol; 2003 Sep; 29(7):580-7. PubMed ID: 12943623
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant radiotherapy and radiochemotherapy in the management of esophageal cancer: a review of the literature.
Carcaterrra M; Osti MF; De Sanctis V; Caruso C; Berardi F; Enrici RM
Rays; 2005; 30(4):319-22. PubMed ID: 16792007
[TBL] [Abstract][Full Text] [Related]
39. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
Fritz P; Stoll P; Wannenmacher M; Zierhut D
Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
[TBL] [Abstract][Full Text] [Related]
40. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
